Ovoca Bio PLC
LSE:OVB

Watchlist Manager
Ovoca Bio PLC Logo
Ovoca Bio PLC
LSE:OVB
Watchlist
Price: 1.7 GBX Market Closed
Market Cap: 1.4m GBX
Have any thoughts about
Ovoca Bio PLC?
Write Note

Relative Value

OVB doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of OVB.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OVB Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.5
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-2.4
Industry
21.9
vs History
1
vs Industry
50
Median 3Y
-1
Median 5Y
-2.5
Industry
16.5
vs History
11
vs Industry
34
Median 3Y
-1.2
Median 5Y
-2.5
Industry
23.6
vs History
60
vs Industry
75
Median 3Y
0.7
Median 5Y
0.6
Industry
2.1
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.2
vs History
87
vs Industry
0
Median 3Y
111.8
Median 5Y
161
Industry
13.3
vs History
87
vs Industry
0
Median 3Y
110.2
Median 5Y
122
Industry
16.6
vs History
vs Industry
1
Median 3Y
70.6
Median 5Y
148.2
Industry
15.6
vs History
vs Industry
1
Median 3Y
70.6
Median 5Y
147.8
Industry
19.1
vs History
14
vs Industry
0
Median 3Y
-84.6
Median 5Y
-75.1
Industry
1.9

Multiples Across Competitors

OVB Competitors Multiples
Ovoca Bio PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IE
Ovoca Bio PLC
LSE:OVB
1.5m GBP 0 -0.5 76.4 73
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IE
Ovoca Bio PLC
LSE:OVB
Average P/E: 32.4
Negative Multiple: -0.5
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top